Integrated Pharmaceuticals, Inc.
INTP
Other OTC0.00
USD
- -
- -
Integrated Pharmaceuticals, Inc.
INTP
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Integrated Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company specializing in the development, production, and distribution of specialty chemicals and nutraceutical products. Its core product offerings include pharmaceutical compounds, vitamins, nutritional supplements, natural botanicals, and raw material distribution. The company operates business segments including contract manufacturing of vitamins and nutritional supplements, and other nutraceutical businesses through its subsidiaries such as Manhattan Drug Company, AgroLabs, The Vitamin Factory, IHT Health Products, MDC Warehousing and Distribution, and Chem International. Integrated Pharmaceuticals serves a diverse customer base including distributors, multilevel marketers, healthcare providers, and mass market retail channels primarily within the United States with some international sales presence. Founded in 1980 and headquartered in Hillside, New Jersey, Integrated Pharmaceuticals has recently maintained its focus on contract manufacturing and nutraceutical goods despite revenue fluctuations. The company reported operating income and revenue changes in 2024 and 2025, reaffirming its steady operations in its core business segments. Recent strategic initiatives include operational improvements in warehousing and distribution as well as expanding its product portfolio of natural health products under brands like Peaceful Sleep. Integrated Pharmaceuticals continues to emphasize quality production, regulatory compliance, and supply chain efficiency in pharmaceutical raw material sourcing and distribution to sustain its market position. Overall, Integrated Pharmaceuticals operates in the healthcare and pharmaceuticals industry, targeting pharmaceutical manufacturers, healthcare providers, and retail markets. Its offerings cover a wide range of pharmaceutical ingredients, dietary supplements, and health-focused nutraceutical products, supported by contract manufacturing capabilities. The company’s strategic focus on specialized product categories and operational enhancements aligns with industry trends towards integrated pharmaceutical solutions and supply chain reliability. This description synthesizes the company's main products and services, its recent financial and operational status, and strategic focus within the pharmaceutical and nutraceutical sectors as of 2024-2025. It reflects the company’s geographic footprint primarily in the U.S. with international distribution and underscores its foundational history and current business framework. This profile highlights Integrated Pharmaceuticals as an established player offering comprehensive pharmaceutical and nutraceutical manufacturing and distribution services.